Rogoff's Parting Shots
Airtime: Fri. May 14 2010 | 8:56 AM ET
Thoughts on where we go from here, with former IMF director Kenneth Rogoff, Harvard’s Thomas D. Cabot Professor of Public Policy.
Airtime: Fri. May 14 2010 | 8:56 AM ET
Thoughts on where we go from here, with former IMF director Kenneth Rogoff, Harvard’s Thomas D. Cabot Professor of Public Policy.
Discussing the SEC’s landmark case against Goldman Sachs, with Andrew Ross Sorkin, NY Times; Jim LaCamp, Microportfolio Advisors; Joseph Grundfest, former SEC commissioner and CNBC’s Kate Kelly.
Study Identifies Heart Risks in Glaxo’s Avandia. Dr. Steven Nissen, of the Cleveland Clinic, authored a controversial study identifying heart risks in GlaxoSmithKline’s Avandia diabetes drug. He talks to CNBC’s Mike Huckman.
CNBC’s Becky Quick talks to Berkshire-Hathaway CEO and billionaire investor Warren Buffett about Goldman Sachs, his company, the economy and his reservations about the financial reform proposal currently being debated in the Senate.
Countdown to the opening bell, with Art Cashin, UBS.
Discussing whether fear will continue to push gold even higher, with Anthony Neglia, of Tower Trading, and CNBC’s Sharon Epperson.
Chris Whalen, managing director of Institutional risk Analytics, shares his reaction to Citi’s quarterly results.